Sequent Scientific (BOM:512529) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1991. Start your Free Trial

What is Sequent Scientific Change In Receivables?

Sequent Scientific's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Sequent Scientific's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Sequent Scientific's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-479 Mil. It means Sequent Scientific's Accounts Receivable increased by ₹479 Mil from Mar. 2024 to Mar. 2025 .

Sequent Scientific's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹3,632 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sequent Scientific's Days Sales Outstanding for the three months ended in Mar. 2025 was 82.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sequent Scientific's liquidation value for the three months ended in Mar. 2025 was ₹-2,963 Mil.

Sequent Scientific Change In Receivables Historical Data

The historical data trend for Sequent Scientific's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Change In Receivables Chart

Sequent Scientific Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

Get a 7-Day Free Trial

-394.75

-407.24

-412.64

-87.82

-479.40

Sequent Scientific Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Sequent Scientific Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Sequent Scientific (BOM:512529) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sequent Scientific's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3631.7	/	4017	*	91
=	82.50

2. In Ben Graham's calculation of liquidation value, Sequent Scientific's accounts receivable are only considered to be worth 75% of book value:

Sequent Scientific's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	702.4	-	8315.9	+	0.75 * 3631.7	+	0.5 * 3853.2
=	-2,963

Sequent Scientific Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequent Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » Change In Receivables

Traded in Other Exchanges

SEQUENT:India

Address

Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604

Website

https://www.sequent.in

Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines